Toronto - Delayed Quote
CAD
Sernova Biotherapeutics Inc (SVA.TO)
0.1100
+0.0050
(+4.76%)
At close: November 6 at 3:59:37 PM EST
Loading chart for SVA.TO
- Previous Close
0.1050 - Open
0.1050 - Bid 0.1050 x --
- Ask 0.1100 x --
- Day's Range
0.1050 - 0.1100 - 52 Week Range
0.0900 - 0.2000 - Volume
32,010 - Avg. Volume
203,476 - Market Cap (intraday)
41.541M - Beta (5Y Monthly) 0.67
- PE Ratio (TTM)
11.00 - EPS (TTM)
0.0100 - Earnings Date (est.) Dec 17, 2026
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
1.00 - Moby Rating Neutral
Recent News
View MorePerformance Overview
Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
SVA.TO
21.43%
S&P/TSX Composite index (^GSPTSE)
12.31%
1-Year Return
SVA.TO
26.67%
S&P/TSX Composite index (^GSPTSE)
18.89%
3-Year Return
SVA.TO
86.25%
S&P/TSX Composite index (^GSPTSE)
80.53%
5-Year Return
SVA.TO
91.60%
S&P/TSX Composite index (^GSPTSE)
66.80%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-868.43%
-
Return on Equity (ttm)
--
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-10.29M
-
Diluted EPS (ttm)
0.0100
Balance Sheet and Cash Flow
-
Total Cash (mrq)
63.33k
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
-14.83M
